A University of Bath spin-out has secured £1.1m to develop technology it believes could “revolutionise” the treatment of diabetes.
Transdermal Diagnostics (TD) is working towards commercialising a wearable “smart-patch” which it says could be the first completely needle-free blood sugar monitor.
The device is designed to use miniaturised biosensors to sample fluid bathing the living cells of skin. TD says the contraption then measures vital health biomarkers, including sugar, at levels which are very similar to those in blood - without the need to puncture the skin.
